SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q2 EPS of ($0.23), $0.03 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $16 million versus the consensus estimate of $17.4 million.

GUIDANCE:

SOPHiA GENETICS SA sees FY2024 revenue of $65-67 million, versus the consensus of $76.6 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.